Evidence map›Paper›PMID 26774761›Full record

ArticleActa biomaterialia2016

Microfluidic fabrication of bioactive microgels for rapid formation and enhanced differentiation of stem cell spheroids.

Christian Siltanen, Maliheh Yaghoobi, Amranul Haque, Jungmok You, Jeremy Lowen, Masoud Soleimani, Alexander Revzin

Open access · greenAbstract read
In one paragraph

Article in Acta biomaterialia, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
7.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 109 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Microfluidic Chip Device forLangmuir : the ACS journal of surfaces and colloids · 2021
    Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Christian SiltanenUniversity of California, Davis, 451 Health Sciences Dr., Davis, CA, USA. Electronic address: csiltanen@ucdavis.edu.
Maliheh YaghoobiUniversity of California, Davis, 451 Health Sciences Dr., Davis, CA, USA. Electronic address: myaghoobi@modares.ac.ir.
Amranul HaqueUniversity of California, Davis, 451 Health Sciences Dr., Davis, CA, USA. Electronic address: ahaque@ucdavis.edu.
Jungmok YouUniversity of California, Davis, 451 Health Sciences Dr., Davis, CA, USA. Electronic address: jmyou@khu.ac.kr.
Jeremy LowenUniversity of California, Davis, 451 Health Sciences Dr., Davis, CA, USA. Electronic address: jlowen@ucdavis.edu.
Masoud SoleimaniUniversity of California, Davis, 451 Health Sciences Dr., Davis, CA, USA. Electronic address: soleim_m@modares.ac.ir.
Alexander RevzinUniversity of California, Davis, 451 Health Sciences Dr., Davis, CA, USA. Electronic address: arevzin@ucdavis.edu.
University of California, Davis · US

Funding

Training Program in Biomolecular TechnologyT32GM008799 · NIGMS · UNIVERSITY OF CALIFORNIA DAVIS · PI LEACH, J. KENT · 2002 to 2016
$2.4M
Designing a Microenvironment Niche for Liver-Specific Differentiation of hESCsR01DK079977 · NIDDK · UNIVERSITY OF CALIFORNIA AT DAVIS · PI REVZIN, ALEXANDER · 2010 to 2014
$1.8M
NIDDK NIH HHS NIH-R01-DK079977NIDDK NIH HHS R01 DK079977NIGMS NIH HHS NIH T32-GM008799NIGMS NIH HHS T32 GM008799
6 · The paper itself

Abstract

A major challenge in tissue engineering is to develop robust protocols for differentiating ES and iPS cells to functional adult tissues at a clinically relevant scale. The goal of this study is to develop a high throughput platform for generating bioactive, stem cell-laden microgels to direct differentiation in a well-defined microenvironment. We describe a droplet microfluidics system for fabricating microgels composed of polyethylene glycol and heparin, with tunable geometric, mechanical, and chemical properties, at kHz rates. Heparin-containing hydrogel particles sequestered growth factors Nodal and FGF-2, which are implicated in specifying pluripotent cells to definitive endoderm. Mouse ESCs were encapsulated into heparin microgels with a single dose of Nodal and FGF-2, and expressed high levels of endoderm markers Sox17 and FoxA2 after 5 days. These results highlight the use of microencapsulation for tailoring the stem cell microenvironment to promote directed differentiation, and may provide a straightforward path to large scale bioprocessing in the future. STATEMENT OF SIGNIFICANCE: Multicellular spheroids and microtissues are valuable for tissue engineering, but fabrication approaches typically sacrifice either precision or throughput. Microfluidic encapsulation in polymeric biomaterials is a promising technique for rapidly generating cell aggregates with excellent control of microenvironmental parameters. Here we describe the microfluidic fabrication of bioactive, heparin-based microgels, and demonstrate the adsorption of heparin-binding growth factors for enhancing directed differentiation of embryonic stem cells toward endoderm. This approach also facilitated a ∼90-fold decrease in consumption of exogenous growth factors compared to conventional differentiation protocols.

Indexed as

AdsorptionAnimalsBiocompatible MaterialsCell DifferentiationCells, ImmobilizedCell SurvivalEmbryoid BodiesEndodermGelsHeparinIntercellular Signaling Peptides and ProteinsMiceMicrofluidicsMouse Embryonic Stem CellsRheologySpheroids, CellularBiocompatible MaterialsGelsHeparinIntercellular Signaling Peptides and ProteinsDroplet microfluidicsEmbryoid bodyEndodermHeparin hydrogelMicrogelNodal

Identifiers

PMID26774761
PMCPMC4811722
OpenAlexW2238761406

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.